Spontaneous pneumothorax is the accumulation of air in the pleural space without preceding trauma, classified as primary (PSP, no clinically apparent lung disease) or secondary (SSP, underlying lung pathology). It is characterized by acute pleuritic chest pain and dyspnea, with management guided by clinical stability and symptom severity rather than pneumothorax size alone. [1-2]
1. History
- Onset and activity: Most PSP episodes occur at rest; ask about activity at onset [3]
- Pain characterization: Acute ipsilateral pleuritic chest pain — initially "sharp," later a "steady ache"; dyspnea is nearly universal [3]
- Timing: Symptoms typically resolve within 24 hours even if pneumothorax persists [3]
- Smoking history: Tobacco (dose-response relationship), cannabis, and vaping — cannabis causes accelerated bullous disease [4-5]
- Prior episodes: Previous ipsilateral pneumothorax is a significant risk factor for treatment failure and recurrence [6]
- Menstrual history in women: Catamenial pneumothorax occurs within 72 hours of menses onset, typically right-sided, in women aged 30–40 with pelvic endometriosis [3]
- Connective tissue disorders: Ask about Marfan syndrome, Ehlers-Danlos, Birt-Hogg-Dubé syndrome [5]
- Underlying lung disease: COPD, asthma, cystic fibrosis, tuberculosis, interstitial lung disease, Langerhans cell histiocytosis, lymphangioleiomyomatosis [3]
2. Alarm Features
- Tension pneumothorax: Tachycardia >135 bpm, hypotension, cyanosis, tracheal deviation, jugular venous distension [3][7]
- Hemodynamic instability: SBP <90 mmHg, HR ≥ SBP, RR >30, SpO₂ <90% on room air [8]
- Bilateral pneumothorax: Rare but life-threatening
- SSP in patients with limited pulmonary reserve: Potentially fatal — COPD patients with FEV₁ <1 L or FEV₁/FVC <40% are at highest risk [3]
- Enlarging pneumothorax on serial imaging with worsening symptoms
- Subcutaneous emphysema suggesting ongoing air leak
3. Medications
- Analgesia: Acetaminophen first-line; NSAIDs (ibuprofen) for pleuritic pain; oral or IV opioids as needed for refractory pain [8-9]
- Local anesthetic: Lidocaine (up to 3 mg/kg) for procedural analgesia during aspiration or chest tube insertion [10]
- Intrapleural bupivacaine: Shown to reduce pain with indwelling chest drains [11]
- Supplemental oxygen: Accelerates pleural air reabsorption by a factor of four (from ~1.25% to ~5% per day) [3]
- Cautions: Avoid excessive sedation in patients with SSP and limited respiratory reserve; avoid positive-pressure ventilation if possible (risk of tension conversion)
- Pleurodesis agents: Minocycline, talc, doxycycline, or autologous blood patch for recurrence prevention [9][12]
4. Diet
- No specific dietary triggers or restrictions
- Ensure adequate hydration, particularly if hospitalized
- Nutritional optimization in patients with low BMI — anorexia nervosa is associated with prolonged air leak and increased contralateral recurrence [5]
5. Review of Systems
- Pulmonary: Dyspnea, cough, pleuritic chest pain, hemoptysis (suggests underlying pathology)
- Cardiac: Palpitations, syncope (tension physiology)
- Dermatologic: Skin lesions (fibrofolliculomas in Birt-Hogg-Dubé), skin laxity (connective tissue disorders)
- Musculoskeletal: Joint hypermobility, tall stature, arm span > height (Marfan)
- GU/GYN: Menstrual timing (catamenial pneumothorax), endometriosis history
- Constitutional: Weight loss, night sweats (TB, malignancy)
6. Collateral History and Family History
- Family history of pneumothorax: Birt-Hogg-Dubé syndrome (FLCN mutations) may be present in 5–10% of PSP patients — warrants screening for renal tumors [5]
- Inherited connective tissue disorders: Marfan syndrome, Ehlers-Danlos, homocystinuria, α₁-antitrypsin deficiency [5]
- Social history: Tobacco and cannabis use, occupation (diving, flying), recreational drug use (inhaled nitrous oxide)
7. Risk Factors
- Smoking: Most important modifiable risk factor; up to 22× increased risk in moderate smokers; dose-response relationship [4-5]
- Cannabis: Deep inhalation and Valsalva maneuvers cause accelerated bullous disease [5]
- Male sex: Incidence 18–28 per 100,000 men vs. 1.2–6 per 100,000 women per year [13]
- Tall, thin body habitus: Classic PSP phenotype [14]
- Age: PSP peaks at ages 15–34; SSP predominates after age 50 [15]
- Low BMI (<18.5 kg/m²): Associated with prolonged air leak and contralateral recurrence [5]
- Underlying lung disease (for SSP): COPD (most common), cystic fibrosis, TB, Pneumocystis pneumonia, LAM, Langerhans cell histiocytosis [3]
- Prior pneumothorax: Recurrence risk exceeds 50% after a first episode; after first recurrence, likelihood of second recurrence is very high [16]
8. Differential Diagnosis
- Pulmonary embolism: Pleuritic chest pain + dyspnea; differentiated by risk factors, D-dimer, CTPA
- Acute coronary syndrome: Chest pain ± dyspnea; ECG and troponin distinguish
- Pericarditis/myocarditis: Positional pleuritic pain, friction rub, diffuse ST changes
- Pleural effusion: Dullness to percussion (vs. hyperresonance)
- Pneumonia/pleuritis: Fever, productive cough, focal consolidation
- Esophageal rupture (Boerhaave): Post-emetic, subcutaneous emphysema, left pleural effusion [17]
- Aortic dissection: Tearing pain, pulse differential, widened mediastinum
- Musculoskeletal chest pain: Reproducible tenderness, no respiratory findings
- Rib fracture: Trauma history, point tenderness, crepitus
9. Past Medical History
- Prior pneumothorax episodes (ipsilateral or contralateral) and treatments received
- Known COPD, asthma, cystic fibrosis, TB, HIV/AIDS
- Connective tissue disorders
- Prior thoracic surgery or procedures
- History of mechanical ventilation
- Anorexia nervosa or other causes of low BMI
10. Physical Exam
- Vital signs: Tachycardia is the most common finding; hypotension, tachypnea, and hypoxia suggest tension or large pneumothorax [3]
- Inspection: Decreased chest wall movement on affected side; subcutaneous emphysema
- Palpation: Decreased tactile fremitus on affected side
- Percussion: Hyperresonance on affected side
- Auscultation: Diminished or absent breath sounds on affected side [3][17]
- Tension signs: Tracheal deviation away from affected side, JVD, cyanosis — though classic signs are poorly sensitive [18]
- Marfanoid habitus: Tall stature, arachnodactyly, pectus deformity
- Small pneumothorax may have a completely normal exam [3]
11. Lab Studies
- ABG: Increased A-a gradient, acute respiratory alkalosis typical; PaO₂ ≤90 mmHg suggests SSP [3][19]
- CBC: Baseline; leukocytosis may suggest infection
- BMP: Baseline for hospitalized patients
- Type and screen: If procedural intervention anticipated
- α₁-antitrypsin level: Consider in recurrent or atypical cases
- Labs are generally not diagnostic — pneumothorax is a clinical and radiographic diagnosis
12. Imaging
- Chest X-ray (upright PA): First-line; look for a thin visceral pleural line displaced from the chest wall [3]
- Expiratory films do not significantly improve diagnostic yield [3]
- Size definitions vary: ACCP = ≥3 cm apex-to-cupola; BTS = ≥2 cm at hilum [16]
- Point-of-care ultrasound: Sensitivity ~89%, specificity ~99% — superior to CXR; look for absent lung sliding, absent B-lines/comet-tail artifacts, and presence of lung point (pathognomonic) [20-21]
- CT chest: Gold standard for size quantification and identifying underlying pathology (blebs, bullae, emphysema, cystic lung disease); reserve for complex cases, recurrence, or suspected SSP [1][22]
- CXR is sufficient for most initial presentations; CT not routinely needed at first episode [22]
13. Special Tests
- Point-of-care ultrasound (POCUS): Absent lung sliding + absent B-lines + lung point = pneumothorax confirmed; M-mode shows "barcode/stratosphere sign" vs. normal "seashore sign" [20]
- Digital air-leak monitoring: Reduces chest tube duration and hospital LOS [16]
- Light Index: Estimates pneumothorax size as percentage of hemithorax [13]
- Pulmonary function tests: Post-recovery in SSP patients to assess underlying disease severity; FEV₁ <1 L or FEV₁/FVC <40% indicates high-risk SSP [3]
- Genetic testing: Consider FLCN gene testing for Birt-Hogg-Dubé in recurrent or familial cases [5]
14. ECG
- Indications: Obtain to rule out ACS/PE in patients presenting with chest pain and dyspnea
- Common findings: Sinus tachycardia (most common)
- Left-sided pneumothorax: Rightward axis deviation, decreased precordial R-wave voltage, T-wave inversions in precordial leads — can mimic anterior MI
- Right-sided pneumothorax: P-pulmonale, phasic QRS voltage variation (electrical alternans-like pattern), vertical P-wave axis [23]
- Tension pneumothorax: Extreme axis deviation, low voltage, PEA pattern
- All ECG abnormalities typically resolve after lung re-expansion [23]
15. Assessment
- PSP: Typically benign course in young, otherwise healthy patients; most resolve spontaneously or with minimal intervention [3]
- SSP: Potentially life-threatening due to limited cardiopulmonary reserve; requires more aggressive management [3]
- Severity stratification: Based on clinical stability (vitals, symptoms, ability to mobilize) rather than radiographic size alone [1-2]
- Recurrence: ~30% after first PSP; >50% after any spontaneous pneumothorax per some estimates; highest within the first year (77.8% of recurrences) [16][24]
- Complications: Tension pneumothorax, persistent air leak (>3–5 days), re-expansion pulmonary edema (rare, with rapid re-expansion of chronically collapsed lung), hemopneumothorax
16. Treatment Plan
Initial stabilization:
- ABCs; high-flow supplemental oxygen (accelerates reabsorption 4×) [3]
- Immediate needle decompression (2nd ICS, midclavicular line) if tension pneumothorax suspected, followed by tube thoracostomy [7]
PSP — Clinically stable, minimally symptomatic:
- Conservative managementEuropean Journal of Cardio-Thoracic Surgery + 1[2][8]
PSP — Symptomatic or large:
- Needle aspiration is strongly recommended over chest tube as initial intervention (ERS 2024). Performed at 2nd ICS midclavicular line with 14–16 gauge catheter; aspirate up to 2.5 L; success rate ~70% [2-3][16]
- If aspiration fails → small-bore chest tube (7–14 Fr) with Heimlich valve or water seal [3]
- Ambulatory management with Heimlich valve device is conditionally recommended, allowing outpatient treatment with daily follow-up [2][10]
SSP:
- Chest tube drainage is the standard approach due to poor pulmonary reserve [1]
- Lower threshold for admission and intervention
- Thoracic surgery consultation early
Persistent air leak (>3–5 days):
- Consider VATS bullectomy ± pleurodesis [16]
- Autologous blood patch pleurodesis is conditionally recommended for SSP patients with persistent air leak [2]
Recurrence prevention:
- Smoking cessation — single most important intervention [1][5]
- VATS with pleurodesis (mechanical abrasion, talc poudrage, or chemical) reduces recurrence to <5% [16]
- Early surgical intervention may be considered at first presentation for patients who prioritize recurrence prevention [2]
17. Disposition
Discharge criteria (PSP):
- Small, stable pneumothorax with minimal symptoms
- Observed 3–6 hours in ED with repeat CXR showing no progression [11]
- Reliable follow-up within 12 hours to 2 days [11]
- Access to emergency services; lives with a responsible person [10]
- Clinically stable vitals, no oxygen requirement, mobile and able to self-care [10]
Admission criteria:
- SSP (all patients should generally be admitted) [3]
- Hemodynamic instability or tension physiology
- Failed aspiration requiring chest tube with water seal
- Significant symptoms despite intervention
- Bilateral pneumothorax
- Unreliable follow-up or distant from emergency services [11]
- Underlying conditions limiting tolerance of recurrence
Surgical consultation triggers:
- Persistent air leak >3–5 days [16]
- Second ipsilateral recurrence (or first recurrence if patient prioritizes prevention) [2]
- Bilateral pneumothorax
- Hemothorax
- High-risk occupations (pilots, divers) after first episode
18. Follow Up / Return Precautions
- Follow-up timing: CXR within 12 hours to 2 days after ED discharge; repeat at 1 week, 1 month, then as needed [9][11]
- Ambulatory device patients: Review every 1–2 days; consider surgery referral if not resolved by day 4 [10]
- Return immediately for: Worsening dyspnea, chest pain, lightheadedness/syncope, or feeling unwell
- Activity restrictions: Avoid strenuous activity until confirmed resolution; avoid air travel until full resolution confirmed on imaging (risk of expansion at altitude); avoid scuba diving permanently unless definitive surgical pleurodesis performed
- Smoking cessation: Counsel strongly — reduces recurrence risk substantially [1][5]
- Expected course: PSP symptoms typically improve within 24 hours; radiographic resolution at ~1.25–2% per day on room air, ~5% per day with supplemental O₂ [3]
- Long-term: Discuss recurrence risk (~30% after first episode) and indications for surgical referral [16]
References
1. Pneumothorax: An Update on Clinical Spectrum, Diagnosis and Management. — Iqbal B, Hallifax R, Rahman NM. Clinical Medicine. 2025.
2. Pneumothorax: An Update on Clinical Spectrum, Diagnosis and Management. — Iqbal B, Hallifax R, Rahman NM. Clinical Medicine. 2025.
3. Pneumothorax: An Update on Clinical Spectrum, Diagnosis and Management. — Iqbal B, Hallifax R, Rahman NM. Clinical Medicine. 2025.
4. Joint ERS/EACTS/ESTS Clinical Practice Guidelines on Adults With Spontaneous Pneumothorax. — Walker S, Hallifax R, Ricciardi S, et al. European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery. 2024.
5. Joint ERS/EACTS/ESTS Clinical Practice Guidelines on Adults With Spontaneous Pneumothorax. — Walker S, Hallifax R, Ricciardi S, et al. European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery. 2024.
6. Spontaneous Pneumothorax. — Sahn SA, Heffner JE. The New England Journal of Medicine. 2000.
7. Spontaneous Pneumothorax. — Sahn SA, Heffner JE. The New England Journal of Medicine. 2000.
8. Conservative Versus Interventional Management for Primary Spontaneous Pneumothorax in Adults. — Ashby M, Haug G, Mulcahy P, et al. The Cochrane Database of Systematic Reviews. 2014.
9. Conservative Versus Interventional Management for Primary Spontaneous Pneumothorax in Adults. — Ashby M, Haug G, Mulcahy P, et al. The Cochrane Database of Systematic Reviews. 2014.
10. Spontaneous Pneumothorax: Time to Rethink Management?. — Bintcliffe OJ, Hallifax RJ, Edey A, et al. The Lancet. Respiratory Medicine. 2015.
11. Spontaneous Pneumothorax: Time to Rethink Management?. — Bintcliffe OJ, Hallifax RJ, Edey A, et al. The Lancet. Respiratory Medicine. 2015.
12. A Retrospective Analysis of Treatment Selection and Risk Factors of Treatment Failure and Recurrence in Patients With Spontaneous Pneumothorax. — Nakano T, Kaneda H, Fukumoto K, et al. Journal of Thoracic Disease. 2023.
13. A Retrospective Analysis of Treatment Selection and Risk Factors of Treatment Failure and Recurrence in Patients With Spontaneous Pneumothorax. — Nakano T, Kaneda H, Fukumoto K, et al. Journal of Thoracic Disease. 2023.
14. Thoracic Trauma WSES-AAST Guidelines. — Coccolini F, Cremonini C, Moore EE, et al. World Journal of Emergency Surgery : WJES. 2025.
15. Thoracic Trauma WSES-AAST Guidelines. — Coccolini F, Cremonini C, Moore EE, et al. World Journal of Emergency Surgery : WJES. 2025.
16. Conservative versus Interventional Treatment for Spontaneous Pneumothorax. — Brown SGA, Ball EL, Perrin K, et al. The New England Journal of Medicine. 2020.
17. Conservative versus Interventional Treatment for Spontaneous Pneumothorax. — Brown SGA, Ball EL, Perrin K, et al. The New England Journal of Medicine. 2020.
18. Simple Aspiration and Drainage and Intrapleural Minocycline Pleurodesis Versus Simple Aspiration and Drainage for the Initial Treatment of Primary Spontaneous Pneumothorax: An Open-Label, Parallel-Group, Prospective, Randomised, Controlled Trial. — Chen JS, Chan WK, Tsai KT, et al. Lancet. 2013.
19. Simple Aspiration and Drainage and Intrapleural Minocycline Pleurodesis Versus Simple Aspiration and Drainage for the Initial Treatment of Primary Spontaneous Pneumothorax: An Open-Label, Parallel-Group, Prospective, Randomised, Controlled Trial. — Chen JS, Chan WK, Tsai KT, et al. Lancet. 2013.
20. Ambulatory Management of Primary Spontaneous Pneumothorax: An Open-Label, Randomised Controlled Trial. — Hallifax RJ, McKeown E, Sivakumar P, et al. Lancet. 2020.
21. Ambulatory Management of Primary Spontaneous Pneumothorax: An Open-Label, Randomised Controlled Trial. — Hallifax RJ, McKeown E, Sivakumar P, et al. Lancet. 2020.
22. Management of Spontaneous Pneumothorax: An American College of Chest Physicians Delphi Consensus Statement. — Baumann MH, Strange C, Heffner JE, et al. Chest. 2001.
23. Management of Spontaneous Pneumothorax: An American College of Chest Physicians Delphi Consensus Statement. — Baumann MH, Strange C, Heffner JE, et al. Chest. 2001.
24. Effectiveness of Chemical Pleurodesis in Spontaneous Pneumothorax Recurrence Prevention: A Systematic Review. — Hallifax RJ, Yousuf A, Jones HE, et al. Thorax. 2017.
25. Effectiveness of Chemical Pleurodesis in Spontaneous Pneumothorax Recurrence Prevention: A Systematic Review. — Hallifax RJ, Yousuf A, Jones HE, et al. Thorax. 2017.
26. Simple Aspiration Versus Intercostal Tube Drainage for Primary Spontaneous Pneumothorax in Adults. — Carson-Chahhoud KV, Wakai A, van Agteren JE, et al. The Cochrane Database of Systematic Reviews. 2017.
27. Simple Aspiration Versus Intercostal Tube Drainage for Primary Spontaneous Pneumothorax in Adults. — Carson-Chahhoud KV, Wakai A, van Agteren JE, et al. The Cochrane Database of Systematic Reviews. 2017.
28. An Unusual Cause of Spontaneous Pneumothorax: Post-Covid-19 Pulmonary Fibrosis. — Ufuk F, Yavas HG, Kis A. The American Journal of Emergency Medicine. 2021.
29. An Unusual Cause of Spontaneous Pneumothorax: Post-Covid-19 Pulmonary Fibrosis. — Ufuk F, Yavas HG, Kis A. The American Journal of Emergency Medicine. 2021.
30. Trends in the Incidence and Recurrence of Inpatient-Treated Spontaneous Pneumothorax, 1968-2016. — Hallifax RJ, Goldacre R, Landray MJ, Rahman NM, Goldacre MJ. The Journal of the American Medical Association. 2018.
31. Trends in the Incidence and Recurrence of Inpatient-Treated Spontaneous Pneumothorax, 1968-2016. — Hallifax RJ, Goldacre R, Landray MJ, Rahman NM, Goldacre MJ. The Journal of the American Medical Association. 2018.
32. Pleural Disease. — Feller-Kopman D, Light R. The New England Journal of Medicine. 2018.
33. Pleural Disease. — Feller-Kopman D, Light R. The New England Journal of Medicine. 2018.
34. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. — Gulati M, Levy PD, Mukherjee D, et al. Journal of the American College of Cardiology. 2021.
35. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. — Gulati M, Levy PD, Mukherjee D, et al. Journal of the American College of Cardiology. 2021.
36. Ultrasound Findings in Tension Pneumothorax: A Case Report. — Inocencio M, Childs J, Chilstrom ML, Berona K. The Journal of Emergency Medicine. 2017.
37. Ultrasound Findings in Tension Pneumothorax: A Case Report. — Inocencio M, Childs J, Chilstrom ML, Berona K. The Journal of Emergency Medicine. 2017.
38. Age > 50 Years and PaO₂ ≤ 90 mmHg Are the Two Dominant Predictive Factors for Secondary Spontaneous Pneumothorax in Male Patients: An Observational Study. — Zhao B, Song X. BMC Pulmonary Medicine. 2026.
39. Age > 50 Years and PaO₂ ≤ 90 mmHg Are the Two Dominant Predictive Factors for Secondary Spontaneous Pneumothorax in Male Patients: An Observational Study. — Zhao B, Song X. BMC Pulmonary Medicine. 2026.
40. Guidelines for the Appropriate Use of Bedside General and Cardiac Ultrasonography in the Evaluation of Critically Ill Patients-Part I: General Ultrasonography. — Frankel HL, Kirkpatrick AW, Elbarbary M, et al. Critical Care Medicine. 2015.
41. Guidelines for the Appropriate Use of Bedside General and Cardiac Ultrasonography in the Evaluation of Critically Ill Patients-Part I: General Ultrasonography. — Frankel HL, Kirkpatrick AW, Elbarbary M, et al. Critical Care Medicine. 2015.
42. Chest Ultrasonography Versus Supine Chest Radiography for Diagnosis of Pneumothorax in Trauma Patients in the Emergency Department. — Chan KK, Joo DA, McRae AD, et al. The Cochrane Database of Systematic Reviews. 2020.
43. Chest Ultrasonography Versus Supine Chest Radiography for Diagnosis of Pneumothorax in Trauma Patients in the Emergency Department. — Chan KK, Joo DA, McRae AD, et al. The Cochrane Database of Systematic Reviews. 2020.
44. ACR Appropriateness Criteria Acute Respiratory Illness in Immunocompetent Patients. — Jokerst C, Chung JH, Ackman JB, et al. Journal of the American College of Radiology : JACR. 2018.
45. ACR Appropriateness Criteria Acute Respiratory Illness in Immunocompetent Patients. — Jokerst C, Chung JH, Ackman JB, et al. Journal of the American College of Radiology : JACR. 2018.
46. Electrocardiographic Manifestations in a Large Right-Sided Pneumothorax. — Yamamoto H, Satomi K, Aizawa Y. BMC Pulmonary Medicine. 2021.
47. Electrocardiographic Manifestations in a Large Right-Sided Pneumothorax. — Yamamoto H, Satomi K, Aizawa Y. BMC Pulmonary Medicine. 2021.
48. Is There a Change in the View of Treatment for Primary Spontaneous Pneumothorax?: The Effect of Thoracic CT and Autologous Blood Pleurodesis: A Retrospective Cohort Study. — Özalp T, Karapinar K. Medicine. 2024.
49. Is There a Change in the View of Treatment for Primary Spontaneous Pneumothorax?: The Effect of Thoracic CT and Autologous Blood Pleurodesis: A Retrospective Cohort Study. — Özalp T, Karapinar K. Medicine. 2024.